15-Second Heart Failure Test: Eko's AI Stethoscope Gets FDA Nod
Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI.
Stay updated with breaking news from Early Detection Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI.
The Eko Low Ejection Fraction Tool will be added to the company's cardiac early detection platform, which already includes various algorithms to inspect heart health.
The FDA has cleared the Eko Low Ejection Fraction Tool, an algorithm intended to aid clinicians in identifying LVEF less than or equal to 40%.
Learn more about research innovations that are exploring the potential of carbon nanotubes-based nanosensors to improve ovarian cancer diagnosis.